InsiderDB

Rep. Carol D. Miller bought Gilead Sciences (GILD)

Rep. Carol D. Miller (R-WV-1) · $1K–$15K · traded Mar 10, 2025

Transaction
Bought
Amount
$1K–$15K
Owner
Not stated
Traded
Mar 10, 2025
Disclosed
Apr 11, 2025
Days to disclose
32
Asset type
Stock
As filed
Gilead Sciences, Inc. - Common Stock
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

  • Sold Pfizer PFE

    $15K–$50K · Traded Mar 10, 2025 · disclosed Apr 11, 2025 · Spouse

    Got $9K from the company’s PAC
  • Bought PepsiCo PEP

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

  • Bought Aflac AFL

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

  • Bought Lockheed Martin LMT

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

    Got $4K from the company’s PAC
  • Bought American Water Works Company AWK

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

    Got $1K from the company’s PAC
  • Sold U.S. Bancorp USB

    $15K–$50K · Traded Mar 10, 2025 · disclosed Apr 11, 2025 · Spouse

  • Bought CME Group CME

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

  • Sold Quest Diagnostics DGX

    $15K–$50K · Traded Mar 10, 2025 · disclosed Apr 11, 2025 · Spouse

    Got $1K from the company’s PAC
  • Bought The Hershey Company HSY

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

  • Sold United Parcel Service UPS

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

    Got $29K from the company’s PAC
  • Bought Illinois Tool Works ITW

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

  • Sold Target TGT

    $15K–$50K · Traded Mar 10, 2025 · disclosed Apr 11, 2025 · Spouse

    Got $2K from the company’s PAC
  • Bought Honeywell International HON

    $1K–$15K · Traded Mar 10, 2025 · disclosed Apr 11, 2025

Recent Congress trades in GILD

Company context for GILD

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. GILDFinancial report·SEC EDGAR

    GILD: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 8:09 PM EDTEvent / period: Sep 30, 2026Original source ↗
  2. GILDCompany announcement·SEC EDGAR

    GILD: Financial results

    Filed 8-K for an event or period dated 2026-10-29. Financial results.

    Public: Oct 29, 2026, 4:03 PM EDTEvent / period: Oct 29, 2026Original source ↗
  3. GILDLobbying report·Lobbying disclosures

    GILD: third_quarter 2026 lobbying report

    Advocate on domestic and global drug pricing proposals, international trade and protection of intellectual property; global supply chain issues, including the Medical Supply Chain Resiliency Act and tariffs; compulsory licensing and other IP issues in multiple countries. Funding for policies relating to domestic and international HIV, Hepatitis C, oncology, and public health activities via appropriations. Advocacy regarding drug pricing proposals, including provisions modifying the Inflation Reduction Act and government purchasing proposals. Advocate on drug pricing proposals. Proposals to exp

    Public: Oct 21, 2026, 1:36 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.